1-1 of 1
visilizumab
Close
Sort by
Journal Articles

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

Clinical Trials & Observations
Paul A. Carpenter, Frederick R. Appelbaum, Lawrence Corey, H. Joachim Deeg, Kris Doney, Theodore Gooley, James Krueger, Paul Martin, Sandra Pavlovic, Jean Sanders, John Slattery, Daniel Levitt, Rainer Storb, Ann Woolfrey, Claudio Anasetti
Journal: Blood
Blood (2002) 99 (8): 2712–2719.
https://doi.org/10.1182/blood.V99.8.2712
Published: 2002